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While the expression of genes that are normally involved in spermatogenesis is frequently detected in tumors, the extent to which these
gene products are required for neoplastic behaviors is unclear. To begin to address their functional relevance to tumorigenesis, we
identified a cohort of proteins which display synthetic lethality with paclitaxel in non-small-cell lung cancer and whose expression is
biased toward testes and tumors. Remarkably, these testis proteins, FMR1NB, NXF2, MAGEA5, FSIP1, and STARD6, are required for
accurate chromosome segregation in tumor cells. Their individual depletion enhances the generation of multipolar spindles, increases
mitotic transit time, and induces micronucleation in response to an otherwise innocuous dose of paclitaxel. The underlying basis for
abnormal mitosis is an alteration in microtubule function, as their depletion increases microtubule cytaster formation and disrupts
microtubule stability. Given these observations, we hypothesize that reactivated testis proteins may represent unique tumor cell vul-
nerabilities which, if targeted, could enhance responsiveness to antimitotic therapy. Indeed, we demonstrate that combining paclitaxel
with a small-molecule inhibitor of the gametogenic and tumor cell mitotic protein TACC3 leads to enhanced centrosomal abnormali-
ties, activation of death programs, and loss of anchorage-independent growth.
Tumor-specific epigenetic alterations allow the activation of a pan-oply of otherwise silenced genetic programs that can be exploited
to promote neoplastic phenotypes. In particular, genes normally in-
volved in development and gametogenesis are frequently found to be
reactivated in tumors, affording an opportunity for transformed cells
to co-opt primordial cell features to confer oncogenic behaviors such
as self-renewal, uncontrolled proliferation, and epithelial-to-mesen-
chymal transition (EMT) (1, 39). Cancer testis (CT) antigens repre-
sent one group of gametogenic proteins whose expression is other-
wise biased toward the testes and reactivated in tumor cells (39).
Because the testes are an immune privileged site, humoral and/or
cellular responses are often elicited to CT antigens in cancer patients.
Thus, much focus has surrounded exploiting these antigens as anti-
cancer vaccine targets, while functional roles, if any, for these proteins
in supporting tumor cell fitness have not been extensively evaluated.
There are over 200 annotated CT antigens, and most have no known
role in spermatogenesis or tumorigenesis (39). However, three recent
studies implicate members of the CT antigen family in tumorigenic
processes, including p53 turnover, centrosome coalescence, mitotic
progression, and regulation of retinoic acid signaling (10, 12, 43).
Furthermore, high expression of specific CT antigens in tumors has
been correlated with significantly poorer outcomes, suggesting that
their reactivation may enhance aggressiveness or chemoresistance (8,
12, 43). Therefore, uncovering roles for CT antigens and other ectop-
ically expressed gametogenic genes could significantly enhance our
understanding of how tumor cells engage otherwise anomalous com-
ponents to support proproliferative activities.
Employing a pangenomic loss-of-function strategy, we previ-
ously found that the CT antigen acrosin binding protein (ACRBP)
supports mitotic spindle fidelity in tumor cells by regulating
NUMA1 protein levels and thereby reinforces bipolar spindle as-
sembly in the presence of paclitaxel (42, 43). These observations
suggest that one role for reactivated spermatogenic proteins is to
buttress mitotic progression, making tumor cells less susceptible
to mitotic perturbations. To develop this hypothesis further, we
asked whether this role was unique to ACRBP or if other CT an-
tigens also functioned to support mitotic progression. To examine
this, we mined a genome-wide small interfering RNA (siRNA)
data set for paclitaxel sensitizer genes that either were classified as
CT antigens or were reported to have a testis-biased expression
pattern. We then assessed the contribution of genes meeting this
criterion to chromosome segregation, bipolar spindle formation,
and interphase microtubule dynamics. Here, we report a novel
role for 5 of these testis proteins, FMR1NB, NXF2, MAGEA5,
FSIP1, and STARD6, in supporting mitosis in NSCLC cells. These
findings suggest that anomalously expressed gene products may
reinforce mitotic progression and thus diminish the negative
impacts of spindle poisons, such as paclitaxel. Direct targeting
of this molecular buffer may enhance the effectiveness of first-
line therapeutics. In support of this hypothesis, we pharmaco-
logically validated the enhanced tumoricidal activity of com-
bining paclitaxel with a small-molecule inhibitor of one of
these testis proteins, TACC3, a well-established component of
the mitotic machinery in tumor cells. These findings may re-
flect a paradigm in which reactivated gametogenic programs
can be engaged by tumor cells to buttress essential processes
that support tumor fecundity.
MATERIALS AND METHODS
Cell culture. NSCLC cell lines were maintained in RPMI medium (Gibco)
with 5% fetal bovine serum (FBS). HBEC30 and HCC4017 cell lines were
maintained in ACL-4 medium (14a) plus 2% FBS. The HBEC3 isogenic
series was a gift from John Minna and has been described previously (31,
34). These cells were maintained in keratinocyte medium supplemented
with supplied epidermal growth factor and bovine pituitary extract
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(Gibco). WHIM12 triple-negative breast cancer cells were a kind gift from
Matthew Ellis (Washington University, St. Louis, MO). LCOV2 cells were
obtained as previously described (43). Paclitaxel (Sigma, Tocris) was re-
suspended in dimethyl sulfoxide (DMSO). Paclitaxel concentrations used
for each cell line were as follows: 10 nM for H1155, HCC366, and H2126;
1.0 nM for HCC515, A549, HCC1993, SUM149, and WHIM12; and 0.1
nM for H460, HCC4017, and HCC15. The identity of all cell lines was
validated by short tandem repeat (STR) analysis at multiple points during
the study. KHS101 was a kind gift from Peter Schultz (44). Additional
KHS101 was synthesized by the UNC Center for Integrative Chemical
Biology and Drug Discovery.
siRNA transfections. Transfection conditions were as described pre-
viously (42); 50 nM siGENOME Smart pools (ThermoFisher) and appro-
priate Dharmafect or RNAiMAX transfection reagent were used. As a
control, we used either a nontargeting siRNA pool or an siRNA pool
targeting DLNB14, for which we have not detected any phenotype upon
depletion. For deconvolutions, individual siRNAs were used at a final
concentration of 75 to 100 nM (42). For TACC3, an independent pool of
siRNAs (ON-TARGETplus) was used for deconvolution at 50 nM.
DNA transfection. cDNAs for myc-tagged genes were reverse trans-
fected into H1299 cells using Lipofectamine 2000. Forty-eight hours post-
transfection, cells were fixed for further analysis.
TABLE 1 Testis or placental genes identified as chemosensitizers from a genome-wide siRNA paclitaxel synthetic lethal screen
Gene Expression pattern
CT
antigena Name Function in the testes/developing gamete
ACRBP Testis enriched (39) Y Acrosin binding protein Binds acrosin in spermatids
FMR1NB Testis enriched (39) Y Fragile X mental retardation neighbor 1 Unknown
NXF2 Testis enriched (39) Y Nuclear RNA export factor 2 mRNA export into the cytoplasm
MAGEA5 Testis enriched (39) Y Melanoma antigen family A, 5 Unknown
STARD6 Testis enriched (4) N StAR-related lipid transfer (START) domain containing 6 Mitochondrial sterol transport
TACC3 Bone marrow and testes (2) N Transforming, acidic coiled-coil containing protein 3 Mitotic spindle formation in embryogenesis
FSIP1 Germ cell, testes (5) N Fibrous sheath interacting protein 1 Component of the sperm flagellum
a Y, yes; N, no.
FIG 1 Testis proteins support mitotic spindle fidelity. (A) H1155 cells were transfected with the indicated siRNAs and exposed to 10 nM paclitaxel for 24 h in
a 96-well format. Cells were stained with anti-phospho-histone 3B (pH3B), and automated counting using a ThermoFisher ArrayScan quantitated the percentage
of cells in mitosis. Error bars represent ranges from the means of 2 independent experiments. (B) H1155 cells stably expressing H2B-GFP were transfected with
the indicated siRNAs. Forty-eight hours posttransfection, cells were exposed to paclitaxel or carrier and imaged by time-lapse microscopy for 48 h. Single-cell
lineage tracing for each condition was performed to measure the length of mitosis as a function of the time from prometaphase to telophase in 50 cells. Quartile
ranges for conditions are shown. P values for differences in timing between the control and target transfected at 10 nM were calculated by Mann-Whitney U test.
***, P  0.001. (C) Representative examples of time-lapse sequences illustrating heterogeneity of fates exhibited by H1155 cells following depletion of indicated
gene products and exposure to a vehicle or 10 nM paclitaxel.
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shRNA transductions. Lentivirus was produced per Open Biosystems
protocol using short hairpin RNA (shRNA) clones in the PLKO.1 vector
from the RNA Consortium. Two hairpins were used per gene, and each
was validated for transcript knockdown.
High-content live-cell imaging. Cell lines expressing histone 2B-
green fluorescent protein (GFP) (H2B-GFP) were generated by viral
transduction as described previously (7). A stable population of H2B-
GFP-expressing cells was obtained through fluorescence-activated cell
sorting (FACS). The stably expressing cell lines were then treated as de-
scribed in the figure legends and imaged on a BD Pathway 855 imager
using a 20 high-numerical-aperture objective. Images were taken ap-
proximately every 15 min for the indicated time periods, and movies were
generated using ImageJ.
Quantitative RT-PCR. For confirmation of gene knockdown, RNA
was harvested from cells transfected with siRNA for 72 h using the Gen-
Elute Mammalian Total RNA Miniprep kit (Sigma). cDNA was generated
using 2 to 4 g of total RNA and the High-Capacity cDNA reverse tran-
scription kit (Applied Biosystems). Real-time PCR (RT-PCR) detection
used inventoried TaqMan gene expression assays purchased from Applied
Biosystems that are designed to exclusively detect mRNA. Amplification
was performed on the 7500 Fast Real Time PCR machine (Applied Bio-
systems). The ribosomal subunit RPL27 was used as the endogenous con-
trol, and differences in expression were calculated using the 2CT
method. For evaluation of gene expression in various human tissues, total
human RNA samples pooled from multiple individuals were obtained
from Clontech.
Immunoblotting. Cells were lysed in boiling sample buffer as de-
scribed previously (7). The primary antibodies used were from Santa Cruz
(glyceraldehyde-3-phosphate dehydrogenase [GAPDH] and TACC3).
Cleaved caspase-3 antibodies were obtained from Epitomics. Secondary
antibodies were horseradish peroxidase-conjugated anti-mouse and anti-
rabbit IgG (Jackson ImmunoResearch).
Immunofluorescence. Conditions for immunofluorescence were as
described previously (7). Briefly, cells were grown on glass coverslips
and fixed at various time points in 3.7% formaldehyde or MeOH,
specifically for -tubulin staining. Primary antibodies used were anti-
-tubulin (Sigma) and antipericentrin (Abcam). Secondary antibod-
ies were Alexa Fluor-conjugated anti-mouse or anti-rabbit antibodies
(Invitrogen). Images were acquired using a Zeiss Axiovision upright
fluorescence microscope with either a 10, 20, or 40 objective. All
images taken to compare samples used identical gain and exposure
settings.
Soft agar assay. H1155 cells (1  104 to 1  106) were resuspended in
0.5% Bacto agar in complete medium and overlaid on solidified 0.5% Bacto
agar in 60-mm dishes. After solidification, a top layer of complete medium
was added. For drug treatments, half the medium from the top layer was
removed and replaced with medium containing 2 the final drug concentra-
tion and 2 fetal bovine serum. Colonies were grown for 2 weeks and then
stained with 0.005% crystal violet in phosphate-buffered saline (PBS) over-
night.
Microtubule regrowth assay. Cells grown on glass coverslips were
depolymerized with 11 M nocodazole (Calbiochem) for 30 min. After
depolymerization, cells were washed and allowed to recover in warm me-
dium. Depolymerized microtubules were extracted in 0.2% Triton X-100
in PHEM buffer (60 mM PIPES [pH 7.0], 25 mM HEPES, 100 mM EGTA,
2 mM MgCl2, 1 M paclitaxel), and slips were then fixed in 3.7% form-
aldehyde. The microtubule network was stained with -tubulin (Sigma),
-tubulin (Sigma), and pericentrin (Abcam). All images for comparison
among samples were acquired using identical exposure and gain settings
using the Zeiss AxioVision software package. For quantitation, individual
cells were circled based on their fluorescent signals. ImageJ calculated the
area and integrated mean intensity. The corrected total cell fluorescence
(CTCF) was calculated as integrated density  (area of selected cell 
mean fluorescence of background reading). At least 50 cells were analyzed
over two experiments.
RESULTS
A cohort of gametogenic proteins is required for accurate chro-
mosome segregation following exposure to low-dose paclitaxel.
We have previously employed a pangenomic loss-of-function ap-
proach to identify components that modulate responsiveness in
NSCLC cells. This strategy revealed that the CT antigen ACRBP
can contribute to mitotic fidelity and paclitaxel sensitivity, sug-
gesting that reactivated testis genes may become tumor cell-selec-
tive dependencies for cell division. To determine if additional CT
antigens or testis genes modulate paclitaxel sensitivity, we com-
bined those genes in the lowest 2.5% rank of paclitaxel sensitizer
ratios with a false-discovery rate of 10% as well as all genes
scoring 2.5 standard deviations below the mean. This data set
contained 409 candidate paclitaxel sensitizers among which we
identified 4 CT antigens (ACRBP, FMR1NB, MAGEA5, and
NXF2) as well as 3 genes with a testis-biased expression pattern
and a documented role in supporting spermatogenesis (FSIP1,
STARD6, and TACC3) (Table 1) (2, 4, 5, 11, 39). We validated
that mRNA encoded by these genes was expressed in the
NSCLC cells employed in the original screen, H1155 (see Fig.
S1A in the supplemental material). In addition, we validated
that the mRNA expression level of these genes was biased to the
testes (see Fig. S1B in the supplemental material). With respect
to spermatogenesis, NXF2, FSIP1, and STARD6 have been im-








FIG 2 Depletion of sperm proteins induces mitotic arrest or defects in H1299
and HCC1171 cells. Cells were transfected with the indicated siRNAs for 48 h,
followed by exposure to 1 nM paclitaxel for 24 h. Cells were immunostained
with antibodies recognizing pH3B and antitubulin. DNA was stained with
4=,6-diamidino-2-phenylindole (DAPI). The percentage of cells in mitosis or
micro- or multinucleated was manually quantitated. H1299 error bars repre-
sent SEMs from 3 independent experiments. *, P  0.05 by Student’s t test.
HCC1171 error bars represent average deviations from the means of 2 inde-
pendent experiments. At least 150 cells were counted per condition in each
experiment.
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and cholesterol transport, respectively (4, 5, 20, 29, 41). A role
for FMR1NB in spermatogenesis has not been reported.
TACC3, which is reactivated in a wide range of tumor types, is
the best-characterized member of this cohort, with a demon-
strated role in embryonic development and differentiation.
However, with the exception of TACC3 and ACRBP, no tumor-
igenic role has been identified for these testis genes (2, 9, 15, 19,
33, 35–37).
Given the phenotypic collaboration observed with the mitotic
spindle poison paclitaxel, we first sought to determine if individ-
ual depletion of members of this cohort (FMR1NB, MAGEA5,
NXF2, FSIP1, STARD6, and TACC3) leads to chromosome seg-
regation defects in the presence of low-dose paclitaxel. We quan-
titated the mitotic index, a measure of potential mitotic error and
arrest, in H1155 NSCLC cells depleted of each testis protein in the
presence and absence of paclitaxel. Disruption of candidates alone
did not significantly impact the accumulation of mitotic figures.
However, exposure of target-depleted cells to 10 nM paclitaxel
increased the frequency of mitotic figures relative to controls, po-
tentially indicating a mitotic arrest (Fig. 1A). To determine if the
enhanced mitotic index reflected an increase in length of mitosis,
we employed live-cell imaging to monitor chromatin dynamics in
real time using H1155 cells stably expressing H2B-GFP. Again,
depletion of individual testis proteins alone did not alter mitotic
transit time compared to the control. However, target-depleted
cells exposed to 10 nM paclitaxel were delayed in mitosis signifi-
FIG 3 Depletion of CT antigens enhances spindle multipolarity and -tubulin
bundles. (A) H1155 cells were transfected with the indicated siRNAs. Forty-
eight hours posttransfection, cells were exposed to either a vehicle or 10 nM
paclitaxel for 24 h. Cell were fixed and immunostained with antibodies specific
for -tubulin (green) and pericentrin (red) as well as DAPI to visualize DNA.
Abnormal mitotics were scored as cells having 2 spindle poles marked by
either pericentrin or -tubulin foci. The average of 3 experiments is graphed.
Error bars represent SEMs. *, P value  0.02 by Student’s t test compared to the
control. (B) Representative epifluorescence images of H1155 cells counted in
panel A (top) and quantitation of colocalization of -tubulin and pericentrin
(bottom). The average of 3 experiments is graphed. Error bars represent SEMs.
*, P value  0.02 by Student’s t test compared to the control. Scale bars repre-
sent 5 m.
FIG 4 FSIP1, STARD6, and NXF2 overexpression enhance chromosome seg-
regation defects. cDNAs encoding indicated myc-tagged proteins were trans-
fected into H1299 cells. Forty-eight hours posttransfection, cells were fixed
and immunostained with anti-myc (red) and anti--tubulin (green) antibod-
ies and DAPI. (Left) Representative images of GFP or anti-myc and DAPI
stain. Scale bars represent 10 m. (Right) Multinucleated cells were scored
microscopically and are graphed as the fraction of total transfected cells. Error
bars represent SEMs from 3 independent experiments. P values were calcu-
lated with Student’s t test.
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cantly longer than the control (Fig. 1B). This increase in timing
was due to an inability of chromosomes to properly align on the
metaphase plate and was aberrantly resolved by mitotic slip-
page that led to either micronucleation or nuclear fragmenta-
tion and/or division into more than 2 daughter cells (Fig. 1C).
Thus, these proteins may contribute to chromosome align-
ment, and their depletion weakens this process sufficiently to
increase the sensitivity of cells to mitotic perturbagens. Indeed,
a similar stress-induced phenotype is observed following dis-
ruption of TACC3, a well-documented component of the mi-
totic spindle (Fig. 1). Similarly, MAD2 knockout flies display a
normal mitosis unless exposed to an antimitotic (6). At least
two individual siRNAs within each pool, or an independent
pool, recapitulated either a mitotic or apoptotic phenotype for
each gene tested (see Fig. S2 in the supplemental material).
To evaluate the functional penetrance of each member of the
testis cohort in additional genetic backgrounds, we examined mi-
totic defects following depletion of each protein together with
exposure to paclitaxel in two additional NSCLC cell lines: H1299
and HCC1171 (Fig. 2). FSIP1 and STARD6 depletion enhanced
paclitaxel-induced mitotic arrest and/or the formation of micro-
nucleated cells in both lines. FMR1NB and NXF2 depletion had
observable consequences on mitosis in H1299 cells but not
HCC1171 cells. Mitotic defects were not observed following de-
pletion of MAGEA5 in either H1299 or HCC1171 cells. As ex-
pected, TACC3 depletion enhanced paclitaxel-induced mitotic
defects in both H1299 and HCC1171 cells. These defects are sim-
ilar to the enhanced mitotic timing and missegregation of chro-
mosomes we observed by live-cell imaging in H1155 cells (Fig. 1B
and C). Thus, the requirement for these testis proteins in support-
ing accurate chromosome segregation during paclitaxel exposure
is a general phenomenon employed in different genetic back-
grounds with some idiosyncratic players, such as MAGEA5 (14).
Depletion of testis proteins disrupts bipolar spindle forma-
tion in the presence of paclitaxel. To determine if members of
this testis cohort influence mitotic spindle architecture, we exam-
ined the distribution of -tubulin and pericentrin in mitotic cells
depleted of these proteins and exposed to 10 nM paclitaxel. We
found that disruption of each of these proteins led to an increase in
the generation of spindles with more than 2 poles in the presence
of 10 nM paclitaxel (Fig. 3A). In the case of MAGEA5 depletion,
the majority of cells showed colocalization for pericentrin and
-tubulin (Fig. 3B). This phenotype was similar to that with
TACC3, which has been reported to contribute to centrosome
clustering in tumor cells, suggesting that MAGEA5 may impact
centrosomal duplication or coalescence (Fig. 3B) (13). On the
other hand, FMR1NB-, NXF2-, STARD6-, and FSIP1-depleted
cells contained multiple cytasters that were -tubulin positive but
pericentrin negative (referred to herein as -tubulin bundles)
(Fig. 3B). -Tubulin has been implicated in supporting de novo
microtubule nucleation, as well as plus-end and lateral microtu-
bule anchoring, thereby promoting acentrosomal microtubule
nucleation during mitosis (22). Thus, these testis proteins may
regulate microtubule nucleation and/or anchoring events in the
mitotic spindle which are disrupted in the presence of paclitaxel.
NXF2, FSIP1, and STARD6 overexpression induces mitotic
errors. Given the mitotic defects associated with depletion of this
cohort of proteins, we evaluated the consequences of their over-
expression in H1299 NSCLC cells. We have previously demon-
strated that overexpression of ACRBP and FMR1NB can inhibit
mitotic arrest induced by high levels of paclitaxel in H1155 cells
(43, 46). A similar observation has also been reported for TACC3
(43, 46). In contrast, we found that overexpression of NXF2,
FSIP1, and STARD6, in the absence of paclitaxel, increased the
generation of multinucleated cells, a hallmark of aberrant mitosis
(Fig. 4). The observation that mitotic defects are increased follow-
FIG 5 Microtubule function is altered in tumor cells and supported by CT antigens. (A) H1299 cells were transfected with the indicated siRNAs. Seventy-two
hours posttransfection, cells were treated with nocodazole for 30 min, fixed, and stained with DAPI (blue), tubulin (green), and pericentrin (red). (Left)
Representative images of immunostained cells; (right) quantitation of fluorescence of immunostained cells. (B) Cells were treated as described for panel A, but
cells were washed of nocodazole and placed in growth medium for 2 min before fixation. Scale bars are 10 m.
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FIG 6 TACC3 is required for high-fidelity mitosis following oncogenic alterations. (A) HBEC3 cells with indicated stable genetic alterations were processed as
for Fig. 5A. Left panels are representative images of immunostained cells. Middle panel is fluorescent quantitation of individual cells. P value was calculated by
the Mann-Whitney U test. Scale bars are 10 m. The right panel is an immunoblot of lysates from HBEC3KT series validating molecular changes. (B) The
indicated HBEC3 cell lines expressing GFP-histone H2B were lentivirally infected with the indicated shRNAs. (Left) Five days postinfection, cells were plated and
imaged by time-lapse microscopy for 48 h. Single-cell lineage tracing for each condition was performed to measure the outcome and length of mitosis as a
function of the time from prometaphase to telophase in 50 cells. Quartile ranges for condition are shown. P values were calculated with the Mann-Whitney test.
(Middle) At 7 days postinfection, cells were immunostained with antitubulin, antipericentrin, and DAPI. Results are averages of two experiments, with the error
bars representing ranges. (Right) Immunoblot indicates TACC3 protein levels following stable knockdown. (C) The indicated cell lines were transfected with
either a control or TACC3-targeting siRNAs. Forty-eight hours posttransfection, cells were exposed to 0.1 nM paclitaxel. (Left) Cells were fixed and stained with
antibodies recognizing tubulin, pH3B, or TACC3 and DAPI. Multinucleated or micronucleated cells were scored by microscopic inspection. Error bars represent
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ing either a decrease or increase in NXF2, FSIP1, or STARD6 pro-
tein levels suggests that they support dynamic processes which,
when disturbed, lead to an aberrant mitosis. Indeed, commensu-
rate phenotypes following gain or loss of function of Aurora-A
and PLK1, key regulators of mitosis, have been reported (21, 25,
26, 28). A similar paradox has also been observed for MAD2, as
either its overexpression or its haploinsufficiency increases tumor
incidence in mice (27, 40). The effects of NXF2, FSIP1, and
STARD6 may be indirect, as we did not observe a strong enrich-
ment of these proteins at the centrosome or on microtubules. We
did find that NXF2 was present in both the nuclear and cytoplas-
mic compartments, consistent with its putative role as an mRNA
transport protein in sperm (Fig. 4) (26). We did not detect any
significant defects following MAGEA5 overexpression, even in the
presence of paclitaxel (data not shown).
Depletion of testis proteins alters microtubule sensitivity to
nocodazole. Since proper microtubule dynamics are essential
for a high-fidelity mitosis, we evaluated whether members of
this cohort had any generalizable consequences on microtu-
bule properties. To do this, we examined the microtubule net-
work in target-depleted H1299 cells following a 30-min pulse
with nocodazole. Under these conditions, a large portion of the
microtubule network was depolymerized, while a small popu-
lation of microtubules remained intact in control cells. How-
ever, RNA interference (RNAi) of FMR1NB, FSIP1, and
TACC3 enhanced depolymerization, leaving few microtubules
intact. Conversely, microtubules in STARD6-depleted cells
were less sensitive to nocodazole (Fig. 5A). siRNA of NXF2 did
not impact depolymerization properties but attenuated cen-
trosomal regrowth at 2 min after nocodazole washout (Fig. 5B).
We did not examine MAGEA5 in this study due to its lack of
phenotype in mitotic assays in H1299 cells. The observed alter-
ations in microtubule stability suggest that these proteins may
be essential for proper microtubule function and could ac-
count for how they enhance paclitaxel sensitivity in tumor
cells.
The dependency of polymer stability on these anomalously
expressed proteins suggests that the microtubule network in tu-
mor cells may have altered properties that require the participa-
tion of unique components compared to nontransformed cells.
Indeed, alterations in the microtubule isotypes have been reported
to occur frequently in breast cancer cells (28). Furthermore, mi-
totic microtubules in tumor cells display enhanced microtubule/
kinetochore attachments compared to normal, immortalized
counterparts (3, 32). To evaluate whether the stability of inter-
phase microtubules is altered during tumor evolution, we assessed
whether molecular changes that induce transformation may also
lead to changes in microtubule dynamics. For this analysis, we
examined microtubule stability in an isogenic cell line series of
immortalized human bronchial epithelial cells (HBEC). This cell
line series begins with an immortalized human bronchial epithe-
lial cell line (HBEC3) that stably expresses CDK4 and hTERT
(HBEC3KT). This parent line is then depleted of p53 alone or in
combination with K-RAS or epidermal growth factor receptor
(EGFR) overexpression (34). In this study, we exposed each of
these different lines to high-dose nocodazole for 30 min and eval-
uated microtubule depolymerization properties. This analysis re-
vealed that microtubules are more sensitive to nocodazole follow-
ing loss of p53. This phenotype was not altered in the presence of
overexpressed K-RAS or EGFR (Fig. 6A).
We next evaluated whether these isogenic cell lines are differ-
entially sensitive to gametogenic gene disruption. We studied
TACC3, as its expression is detectable in HBEC3KT cells. We ex-
amined whether stable TACC3 depletion altered mitotic progres-
sion in each of these cell lines by monitoring mitotic timing and
outcome using live-cell imaging (Fig. 6B). This analysis was per-
formed in the absence of paclitaxel. Depletion of TACC3 in strains
with p53 deletion alone or in combination with RASV12 and
EGFR enhanced both mitotic transit time and the frequency of
abnormal exits, defined as either micro- or multinucleation (Fig.
6B). These abnormal products of mitosis could also be observed in
fixed cells stably depleted of TACC3 (Fig. 6B). Furthermore, tran-
sient TACC3 depletion also enhanced the sensitivity of HCC4017
NSCLC cells to paclitaxel, but no significant impact was observed
in an immortalized nonmalignant bronchial epithelial line,
HBEC30, isolated from the same individual (Fig. 6C). We then
evaluated the penetrance of the mitotic defects observed following
TACC3 perturbation in a panel of lung- and breast tumor-derived
cell lines. We found that TACC3 depletion, in the presence of
low-dose paclitaxel, leads to an increase in mitotic abnormalities
in 4 of the 7 NSCLC cells and the two triple-negative breast cancer
(TNBC) cell lines we assayed (Fig. 6D). Additionally, TACC3 de-
pletion prolonged mitotic transit time and increased abnormal
segregation of chromosomes in ovarian cells isolated from patient
ascites (Fig. 6E). Thus, at least in the case of TACC3, oncogenic
changes can drive a dependency on TACC3 for high-fidelity mi-
tosis in a range of genetic backgrounds, potentially due to under-
lying alterations in the microtubule network.
Gametogenic proteins may represent novel entry points for
therapy. The restricted expression pattern of this cohort of game-
togenic proteins and their requirement for deflecting mitotic per-
turbation suggest that they could represent unique entry points to
enhance paclitaxel sensitivity in tumor cells. The recent discovery
of a TACC3 inhibitor, KHS101, affords the opportunity to evalu-
ate the therapeutic potential of targeting a reactivated gameto-
genic protein to enhance sensitivity to the first-line chemothera-
peutic paclitaxel (44). To evaluate this possibility, we exposed
H1155 cells to a combination of KHS101 and paclitaxel at doses
with little or no single-agent activity. This combination led to
enhanced cleaved caspase-3, unlike the use of either compound as
a single agent (Fig. 7A). The combination also potently impacted
mitosis and increased the accumulation of both mitotically ar-
average deviations for a minimum of 2 independent experiments. (Middle) Representative image of loss of HBEC30 cells transfected with siRNA targeting
TACC3. HBEC30 cells are immunostained with antitubulin (green) and anti-TACC3 (red) and DAPI (blue). Scale bar is 10 m. (Right) Immunoblot with the
indicated antibodies and exposure levels of HBEC30 and HCC4017 lysates transfected with the indicated siRNAs for 72 h. (D) The indicated cell lines were
transfected with either control or TACC3-targeting siRNA. Forty-eight hours posttransfection, cells were exposed to paclitaxel for 24 h with doses described in
Materials and Methods. Cells were fixed and immunostained with antibodies recognizing pH3B, -tubulin, and DAPI. Multi- or micronucleation was scored by
microscopic inspection. Error bars represent deviations from the means for a minimum of 2 independent experiments. (E) (Left) Single-cell lineage tracing in
LCOV2 cells for each condition was performed to measure the outcome and length of mitosis as a function of the time from prometaphase to telophase in 50 cells.
(Right) Quartile ranges for mitotic transit time are shown. P values were calculated with the Mann-Whitney U test.
CT Antigens and Mitosis
October 2012 Volume 32 Number 20 mcb.asm.org 4137
rested and micronucleated cells (Fig. 7B). Examination of the mi-
totic spindle revealed numerous multipolar spindles with multi-
ple, pericentrin-positive foci, a hallmark of TACC3 malfunction
(Fig. 7C) (45). Suggesting that the combination may have effi-
cacy in additional genetic backgrounds, cotreatment of H1299
cells with paclitaxel and KHS101 induced aberrant mitosis
above levels detected for either agent alone (Fig. 7D). We did
not observe defects in normal, immortalized HBEC30 cells co-
treated with paclitaxel and KHS101 (Fig. 7D). In addition, an-
chorage-independent growth was diminished when H1155
cells were exposed to the KHS-paclitaxel combination com-
pared to the use of either agent alone (Fig. 7E). Collectively,
FIG 7 KHS enhances the effectiveness of paclitaxel. (A) H1155 cells were exposed to the indicated amounts of paclitaxel for 24 h, followed by incubation
with the indicated KHS101 concentrations for 48 h. Whole-cell lysates were immunoblotted with the indicated antibodies. (B) H1155 cells were exposed
to the indicated amounts of paclitaxel for 24 h, followed by incubation with the indicated KHS101 concentrations for 24 h, fixed, and immunostained with
anti-pH3B, anti--tubulin, and DAPI. Cells were scored microscopically for mitosis and micronucleation (right). Error bars represent SEMs from 3
independent experiments. Student’s t test was used to calculate P value. Scale bar is 10 m. (C) H1155 cells were treated as for panel A, fixed, and
immunostained with anti--tubulin (green), antipericentrin (red), and DAPI (blue). (Left) Representative images of cells treated as indicated. Scale bar
is 5 m. (Right) quantitation of abnormal spindles that were scored microscopically as any spindle having 2 centrosomes. Error bars represent SEMs
from 3 independent experiments. Student’s t test was used to calculate P value. (D) H1299 and HBEC30 cells were treated with 10 and 0.1 nM paclitaxel,
respectively, and 2 M KHS101 (as indicated) for 48 h and then fixed and immunostained with antitubulin, anti-pH3b, and DAPI. Micronucleated cells
were scored by microscopic inspection. Error bars represent SEMs. Student’s t test was used to calculate P value. (E) H1155 cells were seeded in soft agar
and exposed to the indicated concentrations of paclitaxel and KHS101. Treatments were repeated every 5 days. Colonies were scored microscopically.
Error bars represent SDs for three independent experiments.
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these results reveal that the testis proteins frequently expressed
in tumor can be essential for tumor cell fecundity and thus may
present therapeutic entry points to enhance the efficacy of first-
line chemotherapeutic agents.
DISCUSSION
Here, we describe a role for five testis proteins in supporting
mitotic fidelity in cancer cells. We found that their disruption
perturbs bipolar spindle assembly and chromosome segregation
in the presence of paclitaxel. The altered sensitivity of microtu-
bules to nocodazole following depletion of these proteins suggests
that the observed synergy with paclitaxel could result from a con-
vergence on microtubule stability. Importantly, these proteins ap-
pear to normally have a testis-biased expression pattern, and in
particular, the CT antigens NXF2, FMR1NB, and MAGEA5 are
highly testis restricted and not detectable in normal somatic tis-
sues. In addition to our findings here, we have previously reported
a mitotic role for the CT antigen ACRBP in cancer cells (43). The
roles of these CT antigens in spermatogenesis are unclear; how-
ever, they could represent a coordinated network that, when reac-
tivated in tumor cells, supports mitosis. Thus, our collective find-
ings indicate that reactivated testis proteins are not simply
epiphenomena but may be engaged to support tumor cell division
and fecundity. Importantly, the demonstration that inhibition of
TACC3, a tumor-activated testis protein, can enhance the effects
of paclitaxel in tumor, but not normal, cells indicates the potential
of reactivated testis proteins as therapeutic entry points.
Well-established mitotic proteins, TACC3 and MAD2, share
the stress-induced defects we observed following depletion of this
cohort. The similarity in phenotypes indicates a role for these
testis proteins in supporting mitotic resilience. This finding sug-
gests that tumor cells may maintain a molecular buffer that allows
for the deflection of environmental insults during cell division.
This mitotic robustness may emerge during tumor evolution to
overcome barriers inhibiting accurate chromosome segregation.
For example, our findings that microtubule stability is altered fol-
lowing p53 deletion indicate that tumor suppressor loss, while
restraining cell suicide programs, may have collateral impacts on
the cytoskeleton. Thus, population variants that are able to cir-
cumvent this barrier to outgrowth would have a selective advan-
tage. Anomalous gene expression programs activated during tu-
morigenesis may provide a supply of otherwise unavailable
proteins for overcoming growth inhibition, and we postulate that
reactivated testis proteins may be engaged for this purpose.
Based on our findings here, future molecular analysis will de-
code the mechanisms by which these components serve to directly
or indirectly support mitosis. While minimal information exists
on their role in spermatogenesis, some potential inferences based
on implied roles can be postulated. For example, NXF2 knockout
mice undergo meiotic defects, suggesting that the meiotic role of
NXF2 is hijacked in transformed cells. In particular, NXF2 has
been implicated as an mRNA nuclear transport protein similar to
RAE1, which can alter the microtubule cross-linking activity of
NUMA and impede bipolar spindle formation. Other members of
this cohort have nonmitotic roles in spermatogenesis, suggesting
that they are neomorphically engaged by the tumor cell mitotic
network. For example, FSIP1 is a component of the microtubule-
and dynein-rich fibrous sheath structure, which is essential for
flagellum function and sperm movement. Expression levels of
FSIP1 are elevated in breast cancer, suggesting that its activation is
frequent and may be important functionally (30; see also https://
www.oncomine.org/resource/login.html). Given that tumor cells
lack flagella, FSIP’s microtubule and dynein regulatory properties
may be anomalously engaged to support the microtubule network
and reinforce mitotic robustness in tumor cells. Furthermore,
FSIP1 interacts with a number of additional proteins in the fibrous
sheath, AKAP3, AKAP4, ROPN1, SPA17, and CABYR, which are
all classified as CT antigens (5, 11, 17). ODF2 and SPAG5 are also
fibrous sheath proteins that are required for centrosome and ki-
netochore function in tumor cells (16, 18, 23, 24, 38). Thus, the
elements that regulate the microtubule-rich fibrous sheath struc-
ture could be coordinately reactivated in tumor cells, as they may
confer mitotic robustness. Revealing the proximal mechanistic
connections of these testis proteins to mitotic spindle function has
great potential for uncovering differences between mitosis in tu-
mor and normal cells. Concomitantly, this mechanistic elabora-
tion may also identify additional therapeutic entry points to en-
hance the tumoricidal activity of paclitaxel or other first-line
microtubule-disrupting agents.
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